Abstract:Extracellular vesicles (EVs) have emerged as important carriers for intercellular communication and biological sources for diagnosis and therapeutics. Low efficiency in EV isolation from biofluids, however, severely restricts their downstream characterization and analysis. Here, we introduced a novel strategy for EV isolation from urine for prostate cancer diagnosis using bifunctionalized magnetic beads through high affinity Ti(IV) ions and the insertion of a phospholipid derivative, 1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine, into the EV membrane synergistically. We demonstrated its efficient isolation of EVs from urine samples with low contamination, high recovery (>80%), and short separation time (within 1 h), resulting in the identification of 36,262 unique EV peptides corresponding to 3302 unique proteins and 3233 unique phosphopeptides representing 1098 unique phosphoproteins using only 100 μL and 5 mL urine samples, respectively. Coupled with trapped ion mobility spectrometry and parallel accumulation–serial fragmentation for phosphosite-specific resolution, quantitative phosphoproteomics of urine samples from prostate cancer patients and healthy individuals revealed 121 upregulated phosphoproteins in cancer patients in contrast to the healthy group. These particular advantages indicate that the novel bifunctional material enables sensitive EV phosphoproteomic analysis for noninvasive biomarker screening and early cancer diagnosis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c19400?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c19400</a>.FTIR, zeta potential, and fluorescence characterization of the different MBs-based materials (Figure S1); size distribution characterization of EVs isolated using UC, TiMBs, and DspeMBs (Figure S2); whole proteome overlap among different methods and top proteins of exosome and the phosphopeptides analysis of different isolation methods (Figure S3); Pearson correlation of EV proteomes of the clinical urine samples (Figure S4); the interaction pathway of the upregulated phosphoproteins (Figure S5); fold increase in these 13 exosomal proteins and 3 free urine proteins from LC–MS data of different methods compared to the UC sample (Table S2); and the list of the cancer-associated upregulated phosphoproteins (Table S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_001.pdf">PDF</a>)LC–MS whole proteome analysis data of EVs isolated by different methods (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_002.xlsx">XLSX</a>)LC–MS phosphoproteome analysis data of EVs isolated by different methods (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_003.xlsx">XLSX</a>)LC–MS prostate cancer-specific EV phosphoproteins analysis data (Table S4) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_004.xlsx">XLSX</a>)Mobility resolution of phosphorylation site isomers in urine EVs from prostate cancer patients (Table S6) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_005.xlsx">XLSX</a>)This article has not yet been cited by other publications.

Assessment of urine sample collection and processing variables for extracellular vesicle-based proteomics

High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis

Proof-of-Concept Workflow for Establishing Reference Intervals of Human Urine Proteome for Monitoring Physiological and Pathological Changes

Hands-Free Proteomic Profiling of Urinary Extracellular Vesicles with a High-Throughput Automated Workflow

An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.

One-Pot Sequential Enrichment of Urinary Extracellular Vesicle and miRNAs Identifies a Noninvasive Biomarker Panel for Prostate Cancer Diagnosis

Nanomaterials-Based Urinary Extracellular Vesicles Isolation and Detection for Non-invasive Auxiliary Diagnosis of Prostate Cancer

Synergistically Bifunctional Paramagnetic Separation Enables Efficient Isolation of Urine Extracellular Vesicles and Downstream Phosphoproteomic Analysis

Single Extracellular Vesicle Analysis Performed by Imaging Flow Cytometry and Nanoparticle Tracking Analysis Evaluate the Accuracy of Urinary Extracellular Vesicle Preparation Techniques Differently

An effective urobilin clearance strategy based on paramagnetic beads facilitates microscale proteomic analysis of urine

Urinary Extracellular Vesicles as a Readily Available Biomarker Source: A Simplified Stratification Method

Urine beyond electrolytes: diagnosis through extracellular vesicles

Single extracellular vesicle analysis performed by imaging flow cytometry in contrast to NTA rigorously assesses the accuracy of urinary extracellular vesicle preparation techniques

Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation

Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study

A Simple and Easy Evaluation Method for Urinary Extracellular Vesicles Quality

Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes

Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances

An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer

Influential factors on urine EV DNA methylation detection and its diagnostic potential in prostate cancer

Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer.